ABSTRACT
BACKGROUND: Bronchial asthma is a chronic airway inflammatory disorder involving lymphocyte activation. Lymphocytes express various surface markers upon activation, including CD25 (IL-2 receptor alpha) on T cells and CD23 on B cells. OBJECTIVES: To evaluate whether the surface markers of activated lymphocytes are useful indicators of the disease activity in bronchial asthma. METHOD: We measured serum sCD25 and sCD23 in 42 patients with mild bronchial asthma, and in 26 normal control, volunteers. They were compared with other markers in asthma (methacholine PC20, pulmonary function, total IgE, blood eosinophil counts). RESULTS: Levels of sCD25 were higher among patients than among normal controls and they correlated significantly with sCD23, and FEV1 %, but, not with methacholine PC20. Levels of sCD23 were not higher among patients than among normal controls and did not correlate with methacholine PC20, pulmonry function and total IgE level. CONCLUSION: It appears that sCD25 is related to airway obstruction in bronchial asthma. But, the clinical implications of these markers should be further examined.
Subject(s)
Humans , Airway Obstruction , Asthma , B-Lymphocytes , Eosinophils , Immunoglobulin E , Lymphocyte Activation , Lymphocytes , Methacholine Chloride , T-Lymphocytes , VolunteersABSTRACT
Cytokine-effects of soluble CD23(sCD23) were investigated in our laboratory. We found that sCD23 prepared by ourself could increase the migration inhibition effect of nomal peripheral blood leukocytes stimulated with PHA. It is proposed that sCD23 may have cytokine-like bioactivities on activated T cell and regulate immune response via an unknown mechanism.